State Board of Administration of Florida Retirement System Has $455,000 Stake in Heska Co. (NASDAQ:HSKA)

State Board of Administration of Florida Retirement System increased its holdings in Heska Co. (NASDAQ:HSKAGet Rating) by 27.2% in the second quarter, Holdings Channel reports. The institutional investor owned 4,811 shares of the medical research company’s stock after buying an additional 1,030 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Heska were worth $455,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its position in shares of Heska by 132.0% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 232 shares of the medical research company’s stock valued at $32,000 after buying an additional 132 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in shares of Heska in the first quarter valued at approximately $57,000. Teacher Retirement System of Texas raised its position in shares of Heska by 7.4% in the first quarter. Teacher Retirement System of Texas now owns 2,124 shares of the medical research company’s stock valued at $294,000 after buying an additional 147 shares in the last quarter. Teachers Retirement System of The State of Kentucky raised its position in shares of Heska by 5.2% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 3,057 shares of the medical research company’s stock valued at $423,000 after buying an additional 150 shares in the last quarter. Finally, Truist Financial Corp raised its position in shares of Heska by 13.2% in the first quarter. Truist Financial Corp now owns 4,202 shares of the medical research company’s stock valued at $581,000 after buying an additional 489 shares in the last quarter. 97.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HSKA has been the subject of several research analyst reports. StockNews.com initiated coverage on shares of Heska in a research report on Wednesday, October 12th. They set a “hold” rating for the company. Morgan Stanley lowered their price objective on shares of Heska from $149.00 to $135.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 9th. JPMorgan Chase & Co. lowered their price objective on shares of Heska from $175.00 to $150.00 and set an “overweight” rating for the company in a research report on Monday, October 17th. Piper Sandler lowered their price objective on shares of Heska from $170.00 to $165.00 and set an “overweight” rating for the company in a research report on Monday, November 14th. Finally, Alliance Global Partners lowered their price objective on shares of Heska from $155.00 to $119.00 and set a “buy” rating for the company in a research report on Wednesday, November 9th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $142.25.

Heska Stock Performance

NASDAQ HSKA opened at $64.00 on Friday. The firm’s fifty day moving average price is $73.80 and its two-hundred day moving average price is $85.74. The stock has a market cap of $693.12 million, a PE ratio of -40.76 and a beta of 1.45. Heska Co. has a fifty-two week low of $58.00 and a fifty-two week high of $189.37. The company has a debt-to-equity ratio of 0.24, a quick ratio of 5.61 and a current ratio of 7.18.

About Heska

(Get Rating)

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers.

Read More

Want to see what other hedge funds are holding HSKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heska Co. (NASDAQ:HSKAGet Rating).

Institutional Ownership by Quarter for Heska (NASDAQ:HSKA)

Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.